ramatroban has been researched along with 8-epi-prostaglandin f2alpha in 2 studies
| Studies (ramatroban) | Trials (ramatroban) | Recent Studies (post-2010) (ramatroban) | Studies (8-epi-prostaglandin f2alpha) | Trials (8-epi-prostaglandin f2alpha) | Recent Studies (post-2010) (8-epi-prostaglandin f2alpha) |
|---|---|---|---|---|---|
| 142 | 10 | 28 | 1,863 | 248 | 723 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, ZH; Kawikova, I; Lötvall, J; Okazawa, A; Skoogh, BE | 1 |
| Ishizuka, T; Kurita, A; Matsui, T | 1 |
2 other study(ies) available for ramatroban and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
8-Epi-PGF2alpha induces airflow obstruction and airway plasma exudation in vivo.
Topics: Airway Obstruction; Animals; Bronchoalveolar Lavage Fluid; Carbazoles; Dinoprost; Guinea Pigs; Histamine Antagonists; Male; Methacrylates; Platelet Aggregation Inhibitors; Sulfonamides; Thromboxane A2; Thromboxane B2; Vasoconstrictor Agents | 1997 |
Ramatroban, a TP receptor antagonist, improves vascular responses to acetylcholine in hypercholesterolemic rabbits in vivo.
Topics: Acetylcholine; Animals; Carbazoles; Dinoprost; F2-Isoprostanes; Hypercholesterolemia; Male; Nitroprusside; Rabbits; Receptors, Thromboxane; Sulfonamides; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2003 |